Syros Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Syros Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Syros Pharmaceuticals Inc
Access all reports
Syros Pharmaceuticals Inc. is a biopharmaceutical company focused on developing targeted therapies for cancer and other serious diseases. The company uses its proprietary gene control platform to identify and develop small-molecule drugs that modulate the expression of specific genes associated with disease. Syros's pipeline includes investigational treatments for hematologic cancers, solid tumors, and other genetically defined diseases. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Syros Pharmaceuticals Inc
Corporate Presentation
Syros Pharmaceuticals Inc
Status Update
Syros Pharmaceuticals Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
SYRS
Country
🇺🇸 United States